Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease

Abstract

Intellectual disabilities are genetically heterogeneous and can be associated with congenital anomalies. Using whole-exome sequencing (WES), we identified five different de novo missense variants in the protein phosphatase-1 catalytic subunit beta (PPP1CB) gene in eight unrelated individuals who share an overlapping phenotype of dysmorphic features, macrocephaly, developmental delay or intellectual disability (ID), congenital heart disease, short stature, and skeletal and connective tissue abnormalities. Protein phosphatase-1 (PP1) is a serine/threonine-specific protein phosphatase involved in the dephosphorylation of a variety of proteins. The PPP1CB gene encodes a PP1 subunit that regulates the level of protein phosphorylation. All five altered amino acids we observed are highly conserved among the PP1 subunit family, and all are predicted to disrupt PP1 subunit binding and impair dephosphorylation. Our data suggest that our heterozygous de novo PPP1CB pathogenic variants are associated with syndromic intellectual disability.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

References

  1. Aggen JB, Nairn AC, Chamberlin R (2000) Regulation of protein phosphatase-1. Chem Biol 7(1):R13–R23

  2. Ansai T, Dupuy LC, Barik S (1996) Interactions between a minimal protein serine/threonine phosphatase and its phosphopeptide substrate sequence. J Biol Chem 271(40):24401–24407

  3. Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C et al (2011) Whole-genome sequencing for optimized patient management. Sci Transl Med 3(87):87re3

  4. Barker HM, Brewis ND, Street AJ, Spurr NK, Cohen PT (1994) Three genes for protein phosphatase 1 map to different human chromosomes: sequence, expression and gene localisation of protein serine/threonine phosphatase 1 beta (PPP1CB). Biochim Biophys Acta 1220(2):212–218

  5. Bausen M, Weltzien F, Betz H, O’Sullivan GA (2010) Regulation of postsynaptic gephyrin cluster size by protein phosphatase 1. Mol Cell Neurosci 44:201–209

  6. Bianchi M, De LS, Vietri M, Vietri M, Villa-Moruzzi E (2005) Reciprocally interacting domains of protein phosphatase 1 and focal adhesion kinase. Mol Cell Biochem 272:85–90

  7. Bordelon JR, Smith Y, Nairn AC, Colbran RJ, Greengard P et al (2005) Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex. Cereb Cortex 15(12):1928–1937

  8. Ceulemans H, Vulsteke V, De Maeyer M, Tatchell K, Stalmans W et al (2002) Binding of the concave surface of the Sds22 superhelix to the alpha 4/alpha 5/alpha 6-triangle of protein phosphatase-1. J Biol Chem 277(49):47331–47337

  9. Cohen P, Cohen PT (1989) Protein phosphatases come of age. J Biol Chem 264(36):21435–21438

  10. Cordeddu V, Di Schiavi E, Pennacchio LA, Ma’ayan A, Sarkozy A et al (2009) Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nature Genet 41:1022–1026

  11. Farwell KD, Shahmirzadi L, El-Khechen D, Powis Z, Chao EC et al (2015) Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med 17(7):578–586

  12. Flores-Delgado G, Liu CW, Sposto R, Berndt N (2007) A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis. J Proteome Res 6(3):1165–1175

  13. Genoux D, Haditsch U, Knobloch M, Michalon A, Storm D et al (2002) Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418(6901):970–975

  14. Gibbons JA, Kozubowski L, Tatchell K, Shenolikar S (2007) Expression of human protein phosphatase-1 in Saccharomyces cerevisiae highlights the role of phosphatase isoforms in regulating eukaryotic functions. J Biol Chem 282(30):21838–21847

  15. Gräff J, Koshibu K, Jouvenceau A, Dutar P, Mansuy IM (2010) Protein phosphatase 1-dependent transcriptional programs for long-term memory and plasticity. Learn Mem 17(7):355–363

  16. Gripp KW, Zand DJ, Demmer L, Anderson CE, Dobyns WB et al (2013) Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis. Am J Med Genet 161A:2420–2430

  17. Gripp KW, Aldinger KA, Bennett JT, Baker L, Tusi J et al (2016) A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair. Am J Med Genet A 170(9):2237–2247

  18. Hamdan FF, Srour M, Capo-Chichi JM, Daoud H, Nassif C et al (2014) De novo mutations in moderate or severe intellectual disability. PLoS Genet 10(10):e1004772

  19. He X, Sanders SJ, Liu L, De Rubeis S, Lim ET et al (2013) Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Genet 9(8):e1003671

  20. Hoban R, Roberts AE, Demmer L, Jethva R, Shephard B (2012) Noonan syndrome due to a SHOC2 mutation presenting with fetal distress and fatal hypertrophic cardiomyopathy in a premature infant. Am J Med Genet 158A:1411–1413

  21. Homsy J, Zaidi S, Shen Y, Ware JS, Samocha KE et al (2015) De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science 350(6265):1262–1266

  22. Iacobazzi D, Garaeva I, Albertario A, Cherif M, Angelini GD et al (2015) Protein Phosphatase 1 Beta is Modulated by Chronic Hypoxia and Involved in the Angiogenic Endothelial Cell Migration. Cell Physiol Biochem 36(1):384–394

  23. Jouvenceau A, Hédou G, Potier B, Kollen M, Dutar P et al (2006) Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur J Neurosci 24(2):564–572

  24. Kanematsu T, Yasunaga A, Mizoguchi Y, Kuratani A, Kittler JT, Jovanovic JN, Takenaka K, Nakayama KI, Fukami K, Takenawa T, Moss SJ, Nabekura J, Hirata M (2006) Modulation of GABA(A) receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibition. J Biol Chem 281(31):22180–22189

  25. Kelker MS, Page R, Peti W (2009) Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors. J Mol Biol 385(1):11–21

  26. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al (2009) The sequence alignment/map format and SAM tools. Bioinformatics 25(16):2078–2079

  27. Liu R, Correll RN, Davis J, Vagnozzi RJ, York AJ et al (2015) Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations. J Mol Cell Cardiol 87:204–213

  28. Lupski JR, Gonzaga-Jauregui C, Yang Y, Bainbridge MN, Jhangiani S et al (2013) Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy. Genome Med 5(6):57

  29. Maynes JT, Bateman KS, Cherney MM, Das AK, Luu HA et al (2001) Structal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1. J Biol Chem 276(47):44078–44082

  30. Moorhead G, Johnson D, Morrice N, Cohen P (1998) The major myosin phosphatase in skeletal muscle is a complex between the β isoform of protein phosphatase 1 and the MYPT2 gene product. FEBS Lett 438:141–144

  31. Pereira SR, Vasconcelos VM, Antunes A (2011) The phosphoprotein phosphatase family of Ser/Thr phosphatases as principal targets of naturally occurring toxins. Crit Rev Toxicol 41(2):83–110

  32. Peti W, Nairn AC, Page R (2013) Structural basis for protein phosphatase 1 regulation and specificity. FEBS J 280(2):596–611

  33. Pribiag H, Stellwagen D (2013) TNF-α downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA(A) receptors. J Neurosci 33(40):15879–15893

  34. Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F (2006) A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell 22(2):217–230

  35. Saadat M, Kakinoki Y, Mizuno Y, Kikuchi K, Yoshida MC (1994) Chromosomal localization of human, rat, and mouse protein phosphatase type 1 beta catalytic subunit genes (PPP1CB) by fluorescence in situ hybridization. Jpn J Genet 69(6):697–700

  36. Shang L, Henderson LB, Cho MT, Petrey DS, Fong CT et al (2016) De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism. Neurogenetics 17(1):43–49

  37. Shimizu N, Ishitani S, Sato A, Shibuya H, Ishitani T (2014) Hipk2 and PP1c cooperate to maintain Dvl protein levels required for Wnt signal transduction. Cell Rep. 8(5):1391–1404

  38. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA et al (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58(21):2241–2247

  39. Vissers LE, Gilissen C, Veltman JA (2016) Genetic studies in intellectual disability and related disorders. Nat Rev Genet 17(1):9–18

  40. Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38(16):e164

  41. Yang Y, Primrose DA, Leung AC, Fitzsimmons RB, McDermand MC, Missellbrook A, Haskins J, Smylie AS, Hughes SC (2012) The PP1 phosphatase flapwing regulates the activity of Merlin and Moesin in Drosophila. Dev Biol 361(2):412–426

  42. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ (2015) Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 national health interview survey. Natl Health. Stat Report 87:1–20

Download references

Acknowledgments

We thank the patients and their families for their generous participation. This work was supported in part by a grant from the Simons Foundation and from the NIH (GM030518), NINDS (NS058529), and NHGRI/NHLBI (HG006542).

Author information

Correspondence to Wendy K. Chung.

Ethics declarations

Conflict of interest

Heather McLaughlin, Megan Cho, Kyle Retterer, Rhonda Schnur, Ingrid Wentzensen, and Sherri Bale are employees of GeneDx. Wendy Chung is a former employee of GeneDx and a paid consultant for Regeneron Pharmaceuticals. JRL has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., serves on the Scientific Advisory Board of the Baylor Miraca Genetics Laboratory, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The other authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 25 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ma, L., Bayram, Y., McLaughlin, H.M. et al. De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease. Hum Genet 135, 1399–1409 (2016). https://doi.org/10.1007/s00439-016-1731-1

Download citation

Keywords

  • Congenital Heart Disease
  • Intellectual Disability
  • Intellectual Disability
  • Okadaic Acid
  • Missense Variant